The Bridge Project is seeking team applications for the annual round of Bridge Project funding, for new projects to commence in Spring, 2018. Teams must be composed of at least one Principal Investigator from DF/HCC and at least one Principal Investigator from the Koch Institute at MIT (or MIT faculty member).
The following is a summary; download the full RFA in the 'Related Files' at the bottom.
|9/25/17 by 5pm|| |
A letter of intent (a simple email to firstname.lastname@example.org) that includes the names and affiliations of your Bridge Project proposal team members and a title or short description of your proposal, including disease area, is due by 5pm on September 25, 2017. IMPORTANT NOTE: We ask for the notification simply to help us anticipate the number of proposals and the number of reviewers we will need. You will not receive an invitation to submit a full proposal. All should prepare a full proposal.
|10/23/17 by 5pm||The deadline for submitting your full proposal is October 23, 2017 at 5pm.|
|11/27/17||Teams will be notified by November 27 if they were selected as finalists and need to prepare a presentation.|
|12/11/17 by 9am||If selected as a finalist, teams will need to submit their budget and budget justification by December 11 (9am); contact Deborah Goff no later than December 4th.|
|12/15/17||The Review Committee Meeting, at which finalists (top ranked teams) present as a team, will take place on Friday December 15, 2017 between 8 am and 2pm. All team members must be available that day for an in-person interview. If your team cannot make this date, or has restrictions time-wise, please let us know when you submit your letter of intent. A team presentation with (preferably) the entire team is required for consideration.|
Areas of focus for applications
Teams may submit proposals focused on any aspect of translational cancer research, for all cancer types). Preference will be given to proposals tackling cancers with high unmet medical need, for which advances in and/or technologies for early detection, more accurate diagnosis, monitoring, treatment, and prevention are urgently required.
This year, we have a special opportunity for proposals tackling ileal carcinoid tumors.
There are three types of awards:
- The “traditional” Bridge Project Grant: $400,000 (total costs) per team per year for up to 2 years ($800,000 total)
- Footbridge Grants: $200,000 (total costs) per team per year for one year. These are intended to allow newly formed teams to strengthen their future Bridge Project application and obtain necessary preliminary data/proof of concept as well as become a “true” team
- Expansion Bridge Grants: up to $750,000 per team (total costs) to support the initiation of a Phase I clinical trial or clinical application
- Full applications should be submitted electronically to: email@example.com
- Download the full RFA in the 'Related Files' at the bottom for more information.
- As a reminder, all DF/HCC members are eligible to apply for these grants.
Please refer questions to Debbie Goff (firstname.lastname@example.org).